APA (7th ed.) Citation

Pasquale Maria Berrino, Milo Gatti, Matteo Rinaldi, Eugenio Brunocilla, Pierluigi Viale, & Federico Pea. (2023). Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections. MDPI AG.

Chicago Style (17th ed.) Citation

Pasquale Maria Berrino, Milo Gatti, Matteo Rinaldi, Eugenio Brunocilla, Pierluigi Viale, and Federico Pea. Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome Among Urologic Patients with Documented Gram-Negative Infections. MDPI AG, 2023.

MLA (9th ed.) Citation

Pasquale Maria Berrino, et al. Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome Among Urologic Patients with Documented Gram-Negative Infections. MDPI AG, 2023.